These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20828992)

  • 1. Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes.
    Conde-Estévez D; Grau S; Horcajada JP; Luque S
    Int J Antimicrob Agents; 2010 Nov; 36(5):471-2. PubMed ID: 20828992
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label use of antibiotics in hospitalized patients: focus on tigecycline.
    Curcio D
    J Antimicrob Chemother; 2009 Dec; 64(6):1344-6. PubMed ID: 19759045
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.
    Bassetti M; Eckmann C; Bodmann KF; Dupont H; Heizmann WR; Montravers P; Guirao X; Capparella MR; Simoneau D; Sánchez García M
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii5-14. PubMed ID: 23772047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with the first glycylcycline--tigecycline].
    Musch A
    Med Monatsschr Pharm; 2006 May; 29(5):191-2. PubMed ID: 16719269
    [No Abstract]   [Full Text] [Related]  

  • 6. Tigecycline for the treatment of Acinetobacter infections: a case series.
    Gallagher JC; Rouse HM
    Ann Pharmacother; 2008 Sep; 42(9):1188-94. PubMed ID: 18614749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacterial resistance and a new antibiotic: tigecycline].
    Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):209-19. PubMed ID: 17099789
    [No Abstract]   [Full Text] [Related]  

  • 8. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of tigecycline: focus on use for approved indications.
    Vardakas KZ; Rafailidis PI; Falagas ME
    Clin Infect Dis; 2012 Jun; 54(11):1672-4. PubMed ID: 22431809
    [No Abstract]   [Full Text] [Related]  

  • 10. Tigecycline treatment of critically ill patients: the LatinUser experience.
    Curcio D; Vargas SW; Ugarte Ubiergo S; Varón F; Rojas Suarez J; Paz Chávez C; Curiale A;
    Curr Clin Pharmacol; 2011 Feb; 6(1):18-25. PubMed ID: 21235466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What role for tigecycline in infections?
    BMJ Group
    Drug Ther Bull; 2008 Aug; 46(8):62-4. PubMed ID: 18687585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline: a new glycylcycline for treatment of serious infections.
    Noskin GA
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S303-14. PubMed ID: 16080069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection.
    Herpers BL; Vlaminckx B; Burkhardt O; Blom H; Biemond-Moeniralam HS; Hornef M; Welte T; Kuijper EJ
    Clin Infect Dis; 2009 Jun; 48(12):1732-5. PubMed ID: 19435431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline pharmacokinetic/pharmacodynamic update.
    MacGowan AP
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i11-6. PubMed ID: 18684702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four cases of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections treated with tigecycline.
    Munoz-Price LS; Lolans K; Quinn JP
    Scand J Infect Dis; 2006; 38(11-12):1081-4. PubMed ID: 17148081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline (Tygacil).
    Obstet Gynecol; 2006 Jan; 107(1):178-80. PubMed ID: 16394058
    [No Abstract]   [Full Text] [Related]  

  • 17. Tigecycline: a review of a new glycylcycline antibiotic.
    Scheinfeld N
    J Dermatolog Treat; 2005; 16(4):207-12. PubMed ID: 16249141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical first-line treatment with tigecycline for febrile episodes following abdominal surgery in cancer patients.
    Secondo G; Vassallo F; Solari N; Moresco L; Percivale P; Zappi L; Cafiero F; De Maria A
    Int J Antimicrob Agents; 2010 Nov; 36(5):462-6. PubMed ID: 20846833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with tigecycline in the treatment of multiresistant germs in the ICU].
    Curiel Balsera E; Poullet Brea AM; Prieto Palomino MÁ
    Med Intensiva; 2011; 35(5):319-20. PubMed ID: 21130538
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors associated with adherence to guidelines for the use of tigecycline in a tertiary care hospital.
    Grau S; Conde-Estévez D; Luque S; Alvarez-Lerma F; Horcajada JP; Mateu-De Antonio J; Berenguer N; Salas E
    J Chemother; 2010 Oct; 22(5):339-44. PubMed ID: 21123158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.